6 results match your criteria: "National Centre for Infectious Disease Surveillance and Control (CIDSC)[Affiliation]"
Towards elimination of HIV transmission, AIDS and HIV-related deaths in the UK.
HIV Med
June 2018
HIV and STI Department, National Centre for Infectious Disease Surveillance and Control (CIDSC), Public Health England, London, UK.
Objectives: Our objective was to present recent trends in the UK HIV epidemic (2007-2016) and the public health response.
Methods: HIV diagnoses and clinical markers were extracted from the HIV and AIDS Reporting System; HIV testing data in sexual health services (SHS) were taken from GUMCAD STI Surveillance System. HIV data were modelled to estimate the incidence in men who have sex with men (MSM) and post-migration HIV acquisition in heterosexuals.
Effect of HPV vaccination and cervical cancer screening in England by ethnicity: a modelling study.
Lancet Public Health
January 2018
Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK.
Background: Health equality is increasingly being considered alongside overall health gain when assessing public health interventions. However, the trade-off between the direct effects of vaccination and herd immunity could lead to unintuitive consequences for the distribution of disease burden within a population. We used a transmission dynamic model of human papillomavirus (HPV) to investigate the effect of ethnic disparities in vaccine and cervical screening uptake on inequality in disease incidence in England.
View Article and Find Full Text PDFEconomic evaluation of HIV pre-exposure prophylaxis among men-who-have-sex-with-men in England in 2016.
Euro Surveill
October 2017
HIV & STI Department, National Centre for Infectious Disease Surveillance and Control (CIDSC), Public Health England, London, United Kingdom.
Article Synopsis
- * A model predicts that targeting 5,000 MSM at a 3.3 annual HIV incidence could prevent 118 infections under an 86% effectiveness rate and also save costs; lower effectiveness leads to higher costs per quality-adjusted life year (QALY).
- * The analysis highlights the need for significant reductions in PrEP drug costs and further understanding of HIV incidence and adherence to ensure the program is both financially viable and impactful on public health.
infection is uncommon in the British general population: implications for clinical testing and public health screening.
Sex Transm Infect
May 2018
Research Department of Infection and Population Health, University College London, London, UK.
Introduction: Variable use of new molecular assays, asymptomatic infections and a lack of population data mean that the population burden of is uncertain. We investigated the age-specific prevalence of within the sexually active British general population to inform testing strategies.
Methods: Britain's third National Survey of Sexual Attitudes and Lifestyle (Natsal-3) is a probability sample survey of 15 162 individuals aged 16-74 years, undertaken during 2010-2012.
Screening for gonorrhoea using samples collected through the English national chlamydia screening programme and risk of false positives: a national survey of local authorities.
BMJ Open
October 2014
Public Health England, National Centre for Infectious Disease Surveillance and Control (CIDSC), London, UK.
Objectives: To investigate use of dual tests for Chlamydia trachomatis and Neisseria gonorrhoeae on samples collected through the National Chlamydia Screening Programme (NCSP) in England.
Design And Setting: During May-July 2013, we delivered an online survey to commissioners of sexual health services in the 152 upper-tier English Local Authorities (LAs) who were responsible for commissioning chlamydia screening in people aged 15-24 years.
Main Outcome Measures: (1) The proportion of English LAs using dual tests on samples collected by the NCSP; (2) The estimated number of gonorrhoea tests and false positives from samples collected by the NCSP, calculated using national surveillance data on the number of chlamydia tests performed, assuming the gonorrhoea prevalence to range between 0.
Response letter to T Fowler and co-authors - estimating the positive predictive value of opportunistic population testing for gonorrhoea as part of the English Chlamydia Screening Programme.
Int J STD AIDS
August 2014
Public Health England, National Centre for Infectious Disease Surveillance and Control (CIDSC), London, UK.